Drugs in this country cost too darn much. Trump knows it, Americans know it, and yet Big Pharma refuses to budge.
This summer, President Trump threatened heavy action against major drugmakers unless they commit to lowering their U.S. prices to what they charge other nations. Yet, thus far, the industry has refused (except for one company, which committed in late September). That’s a slap in the face to the American people, who already subsidize this industry’s profits more than any nation on earth.
Other countries impose price controls on prescription drugs, so manufacturers make up the difference by charging Americans several times more. Trump called this out for what it is — a shell game at America’s expense — and told the industry to knock it off.
Instead, days ago, PhRMA — the trade group representing much of the industry — dodged the issue entirely,




